2025 · 2nd Quarter (Apr 1 - June 30)
Filed by IPOLICY SOLUTIONS.
Open official filingSource-reported fields
Literal source text
No bill #: legislation to clarify CLIA FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests" HR 1463: Freedom for Laboratory Innovation and Testing Act
Literal federal measure citations: S.J.Res.82, HR 1463
H.R.3152/S.1546: Patent Eligibility Restoration Act
H.R.4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Literal federal measure citations: H.R.4121
CMS Deregulation RFI: prior authorization, NCCI manual inconsistencies, CLFS payment reform
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
